Analyst Harsh Words Spacex Casts Doubt on IPO Prospects
A leading analyst questions SpaceX's IPO math and governance, casting doubt on the deal's potential for investors. He...
Where To Start With Financial Planning
Financial planning can be overwhelming. Find out where to start and set yourself on the path to financial success.
20,577 articlesWalmart Worth Less Than Anthropic Sparks Valuation Debate
Private AI valuations are climbing into the hundreds of billions, eclipsing Walmart's public market value and prompti...
Scrolling UBI: Deloitte’s Fastest-Growing Software Firm
A software company named by Deloitte as North America’s fastest-growing is rolling out a new model that pays users fo...
XRP Price Prediction: XRPL Tops VanEck Ranking as Leader
VanEck’s latest assessment puts XRPL ahead of JPMorgan, Coinbase, and Canton Network. The ranking feeds the ongoing p...
South Korea About Invest in NuScale Power SMR Program
South Korea's possible investment in NuScale Power's SMR program could shift the nuclear landscape and offer new oppo...
Barry Diller’s $12.4 Billion Bet on MGM Shakes Vegas
A consortium led by Barry Diller has proposed a $12.4 billion bid to take MGM Resorts private, a move that could resh...
Anthropic’s Signals This Summer Could Spark AI IPO Race
Anthropic has filed a confidential S-1, triggering a summer wave of AI IPO chatter. Private-market dynamics, competit...
Virgin Galactic’s Stock Having Its Worst Day After Mega Run
Virgin Galactic’s stock having its worst day after a debt-paydown plan triggered dilution fears, snapping a seven-day...
Signet (SIG) 2027 Earnings Outlook: Growth & Risks
This in-depth analysis examines signet (sig) 2027 earnings, focusing on Q1 2027 results, strategic levers, and what i...
Buy, Hold, Sell: Oracle Stock at $245 — Is It a Buy?
Oracle's backlog surge and accelerating AI infrastructure growth are fueling a heated debate on whether the stock is ...
Lee’s BitMine Plans $300M: ETH Treasury Push Strategy
A bold new plan could reshape crypto funding: a $300 million preferred stock sale to back an ETH-heavy treasury built...
DexCom vs Insulet: Which Diabetes Stock Is Best in 2026
DexCom and Insulet sit at the heart of diabetes technology. This in-depth look examines growth drivers, financials, a...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status